Mercer Global Advisors
RIGL icon

Mercer Global Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Mercer Global Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Buy
+3,241
New +$100K ﹤0.01% 3655

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's RIGL Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Rigel Pharmaceuticals (RIGL) in Q2 2026: 3,241 shares worth $127K. The stake represents ﹤0.01% of the portfolio and ranks #3655 among its holdings.

146 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Mercer Global Advisors held 3,241 shares of Rigel Pharmaceuticals worth $127K as of Q2 2026.
  • Rigel Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3655 holding.
  • 146 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.